ARTICLE SUMMARY:
Novel FDA Device Approvals, Breakthrough Designations, Class I Recalls, Warning Letters, and new Predetermined Change Control Plans in April 2026. Updated April 6.
A roundup of FDA’s actions in April 2026.
FDA Output, April 2026
×
